Skip to main content

Table 1 Patient demographics from healthy controls and patients with sarcoidosis included in the current study. Demographics of patients with sarcoidosis according to the presence or absence of Löfgren’s syndrome and X-ray stage are also presented

From: Soluble epoxide hydrolase derived lipid mediators are elevated in bronchoalveolar lavage fluid from patients with sarcoidosis: a cross-sectional study

  Healthy control Sarcoidosis
(All patients)
Sarcoidosis non-Löfgren Sarcoidosis Löfgren Sarcoidosis
X-ray stage I
Sarcoidosis
X-ray stage II
Number 16 41 20 21 22 19
Age, years 23 [23–25] 40 [33–47]e 43 [33–52] 40 [35–43] 41 [36–48] 40 [32–46]
Sex, female/male 8/8 15/26 7/13 8/13 7/15 8/11
CD4/CD8 1.8 [1.4–2.7]a 8.7 [4.8–11.5]e 7.0 [4.3–11.0] 9.6 [4.9–13.0] 9.7 [5.0–12.6] 7.3 [3.8–11.3]
X-ray stage, I/II 22/19 8/12 14/7 22/0 0/19
%FEV1 111 [101–118] 89 [81–100]e 89 [80–101] 89 [82–100] 88 [81–100] 89 [82–101]
%FVC 114 [109–117] 90 [81–99]b,e 91 [79–101]c 90 [82–96]d 90 [81–97]e 91 [81–100]e
  1. Age, CD4/CD8, %FEV1 and %FVC are presented as median [Interquartile range]
  2. an = 13
  3. bn = 28
  4. cn = 16
  5. dn = 12
  6. ep < 0.05, 2 tailed t-test